Pennington, NJ, United States of America

Laura J Hefta

USPTO Granted Patents = 5 



Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 154(Granted Patents)


Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Laura J. Hefta: Innovator in Antibody Technology

Introduction

Laura J. Hefta is a distinguished inventor based in Pennington, NJ, known for her significant contributions to the field of biotechnology. With a total of five patents to her name, Laura has made remarkable strides in developing fully human antibodies, particularly targeting human 4-1BB. Her work holds great promise for treating various diseases, demonstrating the impact of innovation in medical science.

Latest Patents

Among her most recent innovations are patents for fully human antibodies and antigen-binding portions that specifically bind to human 4-1BB. This technology boasts the ability to facilitate the interaction of human 4-1BB with its ligand, enhancing therapeutic potential. Notably, one aspect of her antibody technology is an IgG4 antibody. The patents also encompass methods for administering therapeutically effective amounts of these antibodies to treat diseases, showcasing the dual focus on both innovation and practical application.

Career Highlights

Laura is currently affiliated with Bristol-Myers Squibb Company, a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. Her role at the company has allowed her to contribute to cutting-edge research and development efforts in the fight against various diseases, making her an integral part of the team.

Collaborations

Throughout her career, Laura has collaborated with notable colleagues, including Maria N. Jure-Kunkel and Marc Santoro. These collaborations illustrate the importance of teamwork in advancing scientific knowledge and innovation in the biopharmaceutical sector, demonstrating how shared expertise can lead to groundbreaking discoveries.

Conclusion

In conclusion, Laura J. Hefta exemplifies the spirit of innovation within the biotechnology industry. Her contributions to the development of fully human antibodies against human 4-1BB not only highlight her exceptional skills as an inventor but also signify the broader impact of her work on medical treatments. As she continues to push the boundaries of science, Laura remains a key figure in the ongoing quest for effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…